By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.
Location: United States
Total raised: $283M
Investors 2
| Date | Name | Website |
| 27.05.2022 | OrbiMed | orbimed.co... |
| 08.11.2023 | EcoR1 Capi... | ecor1cap.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.04.2026 | Series C | $108M | Third Rock... |
| 02.11.2023 | Series B | $175M | - |
Mentions in press and media 8
| Date | Title | Description |
| 18.04.2026 | Terremoto Biosciences: $108 Million Series C Raised To Advance AKT1-Selective Oncology And Rare Disease Programs | Terremoto Biosciences, a clinical-stage biotechnology company focused on highly selective small molecule therapies, announced it has closed a $108 million Series C financing to advance its pipeline targeting cancer and rare diseases. The ro... |
| 15.04.2026 | Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors | Terremoto Biosciences has spelt out how the California biotech will use a $108 million series C round to continue its efforts to broaden the covalent drug alphabet. Proceeds from the financing will be used to fund phase 1 studies of the com... |
| 15.04.2026 | Terremoto Biosciences Raises $108M in Series C Funding | Terremoto Biosciences, a San Francisco, CA-based biotechnology company developing highly targeted, small molecule medicines, raised $108M in Series C funding. Backers included new investors RA Capital Management, Deep Track Capital, Osage U... |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital flowing into the industry. While biotech VC investments in 2022 failed to live up to 2021's banner year, the second half still saw a steady st... |
| 02.11.2023 | Terremoto Biosciences Closes $175 Million Series B Financing | - |
| - | 9 top West Coast biotechs that VCs say are poised to take off in the next year | Tayfun Coskun/Anadolu Agency/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Insider asked 12 venture capitalists which biotech startups would take off in the next 12 months.... |
| - | Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Insider asked 12 venture capitalists which biotech startups would take off in the next 12 months. Here are the 23 companie... |
| - | Terremoto Biosciences | “By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.” |